Indolent Behavior of Malignant Bethesda III Nodules Compared to Bethesda V/VI Nodules.

Mayumi EndoJing PengFadi A NabhanPamela BrockIrina AzaryanClarine LongLaura E RyanMatthew D RingelJennifer A Sipos

Published in: The Journal of clinical endocrinology and metabolism (2024)

Cancers with Bethesda III cytology had a less aggressive clinical phenotype with better prognosis compared to V/VI despite histological similarities. The time to remission was shorter in Bethesda III despite a longer interval between diagnosis and surgery. The initial cytological diagnosis may guide management.

Keyphrases

fine needle aspiration
ultrasound guided
minimally invasive
coronary artery bypass
disease activity
young adults
ulcerative colitis
percutaneous coronary intervention
surgical site infection